HK1116796A1 - Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands - Google Patents
Aminoaryl sulphonamide derivatives as functional 5-ht6 ligandsInfo
- Publication number
- HK1116796A1 HK1116796A1 HK08111412.9A HK08111412A HK1116796A1 HK 1116796 A1 HK1116796 A1 HK 1116796A1 HK 08111412 A HK08111412 A HK 08111412A HK 1116796 A1 HK1116796 A1 HK 1116796A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- sulphonamide derivatives
- ligands
- functional
- aminoaryl
- aminoaryl sulphonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Semiconductor Integrated Circuits (AREA)
- Insulated Gate Type Field-Effect Transistor (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1127CH2005 | 2005-08-12 | ||
| PCT/IN2005/000345 WO2007020652A1 (en) | 2005-08-12 | 2005-10-26 | Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1116796A1 true HK1116796A1 (en) | 2009-01-02 |
Family
ID=36130030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK08111412.9A HK1116796A1 (en) | 2005-08-12 | 2008-10-15 | Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7998981B2 (ja) |
| EP (1) | EP1919896B1 (ja) |
| JP (1) | JP5091138B2 (ja) |
| KR (1) | KR101016972B1 (ja) |
| CN (1) | CN101258144B (ja) |
| AT (1) | ATE452885T1 (ja) |
| AU (1) | AU2005335620B2 (ja) |
| BR (1) | BRPI0520579B8 (ja) |
| CA (1) | CA2618636C (ja) |
| CY (1) | CY1110276T1 (ja) |
| DE (1) | DE602005018554D1 (ja) |
| DK (1) | DK1919896T3 (ja) |
| EA (1) | EA013875B1 (ja) |
| ES (1) | ES2337167T3 (ja) |
| HK (1) | HK1116796A1 (ja) |
| MX (1) | MX2008002018A (ja) |
| NO (1) | NO340511B1 (ja) |
| NZ (1) | NZ566495A (ja) |
| PL (1) | PL1919896T3 (ja) |
| PT (1) | PT1919896E (ja) |
| SI (1) | SI1919896T1 (ja) |
| WO (1) | WO2007020652A1 (ja) |
| ZA (1) | ZA200801276B (ja) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101103023B1 (ko) | 2007-01-08 | 2012-01-05 | 수벤 라이프 사이언시스 리미티드 | ５（헤테로시클릴）알킬ｎ（아릴술포닐）인돌 화합물 및 ５ｈｔ６ 리간드로서 이들의 용도 |
| WO2008136017A1 (en) * | 2007-05-03 | 2008-11-13 | Suven Life Sciences Limited | Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands |
| MX2010003765A (es) * | 2007-10-26 | 2010-04-30 | Suven Life Sciences Ltd | Compuestos de aminoarilsulfonamida y su uso como ligandos de la 5-hidroxitriptamina6. |
| US8318725B2 (en) | 2008-09-17 | 2012-11-27 | Suven Life Sciences Limited | Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands |
| EP2521714B1 (en) * | 2010-01-05 | 2015-08-12 | Suven Life Sciences Limited | Aromatic sulfone compounds useful in the treatment of central nervous disorders |
| CN102153884B (zh) * | 2011-02-16 | 2013-06-19 | 连云港清泰化工有限公司 | 一种墨水型染料及其制备方法与用途 |
| US9663498B2 (en) | 2013-12-20 | 2017-05-30 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
| JP6515175B2 (ja) | 2014-07-08 | 2019-05-15 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． | 芳香族ヘテロ環誘導体及びその医薬的適用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2124206C (en) * | 1991-11-25 | 2001-02-27 | John Eugene Macor | Indole derivatives |
| DZ2376A1 (fr) | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
| KR20010021643A (ko) | 1997-07-11 | 2001-03-15 | 피터 기딩스 | 5-ｈｔ6수용체길항제인술폰아미드유도체및그의제조방법 |
| GB9801392D0 (en) | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
| GB9803411D0 (en) | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
| GB9926302D0 (en) | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
| KR20030062440A (ko) * | 2000-12-22 | 2003-07-25 | 와이어쓰 | 5-하이드록시트립트아민-6 리간드로서의헤테로사이클릴알킬인돌 또는 헤테로사이클릴아자인돌화합물 |
| EP1383767A1 (en) | 2001-02-08 | 2004-01-28 | Memory Pharmaceutical Corporation | Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| JP2005500345A (ja) * | 2001-08-03 | 2005-01-06 | ファルマシア・アンド・アップジョン・カンパニー | ５−ｈｔ６受容体親和性を有する５−アリールスルホニルインドール |
| AU2003238339A1 (en) | 2002-02-01 | 2003-09-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
| WO2003066056A1 (en) | 2002-02-05 | 2003-08-14 | Glaxo Group Limited | Method of promoting neuronal growth |
| JP4467307B2 (ja) | 2002-02-22 | 2010-05-26 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | ５−ｈｔ受容体アンタゴニストとしてのピリジルスルホン誘導体 |
| KR100657056B1 (ko) * | 2002-06-05 | 2006-12-13 | 에프. 호프만-라 로슈 아게 | 중추 신경계 장애의 치료를 위한 5-ｈｔ6-수용체조절제로서 1-설폰일-4-아미노알콕시 인돌 유도체 |
| AU2003283265B2 (en) | 2002-10-18 | 2009-03-05 | F. Hoffmann-La Roche Ag | 4-piperazinyl benzenesulfonyl indoles with 5-HT6 receptor affinity |
| AU2003285759B2 (en) | 2002-11-28 | 2010-01-28 | Suven Life Sciences Limited | N-arylsulfonyl-3-aminoalkoxyindoles |
| ATE401307T1 (de) | 2002-11-28 | 2008-08-15 | Suven Life Sciences Ltd | N-arylsulfonyl-2-substituierte indole mit affinität zum serotonin rezeptor, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen |
| WO2004048331A1 (en) | 2002-11-28 | 2004-06-10 | Suven Life Sciences Limited | N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands |
| EP1581538B1 (en) | 2002-12-18 | 2007-02-28 | Suven Life Sciences Limited | Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| WO2005025558A1 (en) * | 2003-09-12 | 2005-03-24 | Applied Reserach Systems Ars Holding N.V. | Sulfonamide derivatives for the treatment of diabetes |
-
2005
- 2005-10-26 PL PL05813800T patent/PL1919896T3/pl unknown
- 2005-10-26 BR BRPI0520579A patent/BRPI0520579B8/pt not_active IP Right Cessation
- 2005-10-26 JP JP2008525723A patent/JP5091138B2/ja not_active Expired - Fee Related
- 2005-10-26 CA CA2618636A patent/CA2618636C/en not_active Expired - Fee Related
- 2005-10-26 CN CN2005800515505A patent/CN101258144B/zh not_active Expired - Fee Related
- 2005-10-26 US US11/990,383 patent/US7998981B2/en not_active Expired - Fee Related
- 2005-10-26 MX MX2008002018A patent/MX2008002018A/es active IP Right Grant
- 2005-10-26 AU AU2005335620A patent/AU2005335620B2/en not_active Ceased
- 2005-10-26 KR KR1020087005968A patent/KR101016972B1/ko active IP Right Grant
- 2005-10-26 AT AT05813800T patent/ATE452885T1/de active
- 2005-10-26 ES ES05813800T patent/ES2337167T3/es active Active
- 2005-10-26 EP EP05813800A patent/EP1919896B1/en active Active
- 2005-10-26 DK DK05813800.9T patent/DK1919896T3/da active
- 2005-10-26 DE DE602005018554T patent/DE602005018554D1/de active Active
- 2005-10-26 EA EA200800573A patent/EA013875B1/ru not_active IP Right Cessation
- 2005-10-26 WO PCT/IN2005/000345 patent/WO2007020652A1/en active Application Filing
- 2005-10-26 PT PT05813800T patent/PT1919896E/pt unknown
- 2005-10-26 NZ NZ566495A patent/NZ566495A/en not_active IP Right Cessation
- 2005-10-26 SI SI200530928T patent/SI1919896T1/sl unknown
-
2008
- 2008-02-06 ZA ZA200801276A patent/ZA200801276B/xx unknown
- 2008-02-08 NO NO20080705A patent/NO340511B1/no not_active IP Right Cessation
- 2008-10-15 HK HK08111412.9A patent/HK1116796A1/xx not_active IP Right Cessation
-
2010
- 2010-02-04 CY CY20101100110T patent/CY1110276T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009504633A (ja) | 2009-02-05 |
| WO2007020652A1 (en) | 2007-02-22 |
| NO20080705L (no) | 2008-05-06 |
| NZ566495A (en) | 2010-06-25 |
| NO340511B1 (no) | 2017-05-02 |
| ZA200801276B (en) | 2009-02-25 |
| CA2618636C (en) | 2011-01-18 |
| PT1919896E (pt) | 2010-02-26 |
| SI1919896T1 (sl) | 2010-04-30 |
| AU2005335620A1 (en) | 2007-02-22 |
| ATE452885T1 (de) | 2010-01-15 |
| EA200800573A1 (ru) | 2008-08-29 |
| EA013875B1 (ru) | 2010-08-30 |
| AU2005335620B2 (en) | 2009-12-10 |
| BRPI0520579B1 (pt) | 2019-08-06 |
| US7998981B2 (en) | 2011-08-16 |
| KR20080039984A (ko) | 2008-05-07 |
| BRPI0520579B8 (pt) | 2021-05-25 |
| BRPI0520579A2 (pt) | 2009-11-10 |
| JP5091138B2 (ja) | 2012-12-05 |
| US20100168168A1 (en) | 2010-07-01 |
| EP1919896A1 (en) | 2008-05-14 |
| EP1919896B1 (en) | 2009-12-23 |
| KR101016972B1 (ko) | 2011-02-25 |
| CN101258144A (zh) | 2008-09-03 |
| CN101258144B (zh) | 2012-05-30 |
| MX2008002018A (es) | 2008-03-27 |
| DE602005018554D1 (de) | 2010-02-04 |
| CY1110276T1 (el) | 2015-01-14 |
| CA2618636A1 (en) | 2007-02-22 |
| PL1919896T3 (pl) | 2010-05-31 |
| ES2337167T3 (es) | 2010-04-21 |
| DK1919896T3 (da) | 2010-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1116796A1 (en) | Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands | |
| PT1888541E (pt) | Compostos de benzo(d)isoxazol-3-il-amina substituídos como analgésicos | |
| MX2009003316A (es) | Derivados de pirazina-2-carboxamida como moduladores receptores de cb2. | |
| JO2686B1 (en) | Vehicles | |
| EA200900048A1 (ru) | Новые карбонилированные (аза)циклогексаны в качестве лигандов d3 рецептора дофамина | |
| TW200740814A (en) | Compounds | |
| PT1877364E (pt) | Derivados fenilacetileno com afinidade para o receptor mglur5 | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| MX2008002805A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico. | |
| WO2007142905A3 (en) | 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands | |
| DE602006018713D1 (de) | Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate | |
| MX2010002760A (es) | Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina-3. | |
| WO2008059339A3 (en) | Isoquinoline derivatives as vanilloid receptor modulators | |
| UA94053C2 (ru) | Замещенные производные 3-сульфонилиндазола в качестве лигандов гидрокситриптамина-6 | |
| MX2008002158A (es) | Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6. | |
| DK2155674T3 (da) | Aminoalkoxy-aryl-sulfonamidforbindelser og anvendelse heraf som 5-HT6-ligander | |
| HK1120424A1 (en) | Carbazole derivatives as functional 5-ht6 ligands | |
| UA89846C2 (ru) | Производные карбоксамида как антагонисты мускариновых рецепторов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20201027 |